GlassScriptPhysician profile
Yoon M Hong
NPI 1750320842
$18,358.55
in general payments reported to CMS, 2019-2025
28 companies · $2,545 in 2025
The $2,545 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,515 · 2020: $854 · 2021: $1,116 · 2022: $3,403 · 2023: $2,241 · 2024: $3,685 · 2025: $2,545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,250 · Travel and Lodging: $3,147 · Food and Beverage: $2,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,250.00 |
| Travel and Lodging | $3,146.74 |
| Food and Beverage | $2,074.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Profound Medical Corp. | $11,957.15 | 2021-2025 | Tulsa-Pro |
| Boston Scientific Corporation | $3,837.69 | 2019-2023 | Rezum Generator |
| Coloplast Corp | $418.70 | 2019-2020 | |
| Neotract INC. | $372.45 | 2019-2020 | |
| Medtronic USA, INC. | $327.47 | 2019-2020 | |
| Medtronic, INC. | $293.70 | 2021 | |
| Siemens Medical Solutions USA, INC. | $154.55 | 2025 | Magnetom Free.Max |
| Procept Biorobotics Corporation | $145.87 | 2021 | |
| Astellas Pharma US INC | $123.75 | 2019-2022 | |
| Pfizer INC. | $116.71 | 2019-2020 | |
| Teleflex LLC | $104.01 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $63.85 | 2020-2021 | |
| Antares Pharma, INC. | $55.95 | 2019-2021 | |
| Axonics, INC. | $55.77 | 2020-2022 | |
| Janssen Biotech, INC. | $49.47 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $32.85 | 2020 | |
| Dentsply Ih INC. | $29.55 | 2020 | |
| Endo Pharmaceuticals INC. | $28.25 | 2019-2020 | |
| Blue Earth Diagnostics | $25.32 | 2021 | |
| Healthtronics Stone Solutions, LLC | $22.89 | 2021 | |
| Abbvie INC. | $21.77 | 2019 | |
| Myriad Genetic Laboratories, INC. | $21.58 | 2021 | |
| Biotissue Holdings INC. | $21.44 | 2021 | |
| Wright Medical Technology, INC. | $19.01 | 2020 | |
| Amniox Medical, INC. | $17.13 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $15.74 | 2020 | |
| Urovant Sciences INC | $13.99 | 2022 | |
| Sagent Pharmaceuticals | $11.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yoon Hong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.